0
Editorial |

The 2011 Cancer Theme Issue: Title and subTitle BreakCall for Papers

Robert A. McNutt, MD, MPH; Boris Pasche, MD, PhD; Phil B. Fontanarosa, MD, MBA
[+] Author Affiliations

Author Affiliations: Department of Medicine, Rush University School of Medicine, Chicago, Illinois (Dr McNutt); Division of Hematology/Oncology and Comprehensive Cancer Center, University of Alabama, Birmingham (Dr Pasche). Drs McNutt and Pasche are Contributing Editors and Dr Fontanarosa (phil.fontanarosa@jama-archives.org) is Executive Editor, JAMA.


JAMA. 2011;305(2):199-199. doi:10.1001/jama.2010.1973
Text Size: A A A
Published online

Along with cancer specialists, such as medical and surgical oncologists and radiation therapists, physicians in virtually every medical specialty will continue to encounter and care for patients with cancer.1 With the current lifetime probability of being diagnosed with invasive cancer estimated at 38% for women and 44% for men,2 virtually all families have had or will have a family member who has been affected with or has died from this disease. Even though care for patients with cancer certainly has improved, many cancers are still associated with significant morbidity, often taking a devastating toll on physical functioning, quality of life, and emotional well-being.

With the hope that publishing new research findings and clinical reports about cancer will prove helpful to physicians and other clinicians who care for patients with cancer, JAMA has always assigned a high priority to manuscripts examining the epidemiology, prevention, treatment, and outcomes of cancer.3 To focus the attention of the medical community on novel research in oncology and to provide clinicians with new information on cancer care, JAMA will publish another theme issue devoted to cancer in June 2011.

Authors are invited to submit manuscripts on any topic relevant to the biology, etiology, epidemiology, prevention, diagnosis, or treatment of oncologic disorders. A high priority will be given to rigorously conducted original research, especially multicenter randomized clinical trials that present new findings on treatment and novel therapeutic approaches for improving outcomes for common cancers. Careful consideration will be given to investigations exploring the genetic, genomic, and biomolecular aspects of cancer, as well as reports of basic science and translational investigations that provide novel insights about the biology, mechanisms, and pathophysiology of cancer. High-quality studies that present new data relevant to comparative effectiveness, improving prevention efforts, optimizing treatment strategies and health care delivery systems, and enhancing understanding of the functional, quality-of-life, and economic consequences of cancer care are also of interest.

We look forward to receiving manuscripts—including original research, systematic reviews, and scholarly commentaries—for consideration for the 2011 theme issue on cancer. We are particularly interested in receiving manuscripts from investigators who will be presenting research papers at the 2011 American Society of Clinical Oncology Annual Meeting, with the potential of publishing their peer-reviewed, full-text articles online in JAMA to coincide with their scientific presentation at the meeting.

Authors are encouraged to consult the Instructions for Authors4  for guidelines on manuscript preparation and submission. All submitted manuscripts will undergo JAMA 's usual rigorous editorial evaluation and review. Manuscripts received before March 1, 2011, will have the best chance of consideration for inclusion in the 2011 JAMA theme issue on cancer.

AUTHOR INFORMATION

Published Online: December 29, 2010. doi:10.1001/jama.2010.1973

Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Pasche reports serving as a consultant for Amgen, Komen Foundation, and the American Association for Cancer Research; serving as a paid expert witness in a hematology/oncology malpractice case; receiving payment for lectures given for multiple academic institutions; owning several patents for which he has received no monetary payment; owning stock in TheraBionic LLC; and receiving grants to his institutions from the American Association for Cancer Research, American Cancer Society, and Mander Foundation. Drs McNutt and Fontanarosa reported no disclosures.

Editorials represent the opinions of the authors and JAMA and not those of the American Medical Association.

Pasche B, McNutt RA, Fontanarosa PB. Caring for patients with cancer.  JAMA. 2010;303(11):1094-1095
PubMedCrossRef
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010.  CA Cancer J Clin. 2010;60(5):277-300
PubMedCrossRef
McNutt RA, Pasche B, Fontanarosa PB. A theme issue on cancer: call for papers.  JAMA. 2009;302(3):327
CrossRef
 JAMA Instructions for Authors. http://www.jama.com/instructions

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Pasche B, McNutt RA, Fontanarosa PB. Caring for patients with cancer.  JAMA. 2010;303(11):1094-1095
PubMedCrossRef
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010.  CA Cancer J Clin. 2010;60(5):277-300
PubMedCrossRef
McNutt RA, Pasche B, Fontanarosa PB. A theme issue on cancer: call for papers.  JAMA. 2009;302(3):327
CrossRef
 JAMA Instructions for Authors. http://www.jama.com/instructions
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
JAMAevidence.com

The Rational Clinical Examination
Make the Diagnosis: Cancer, Family History

The Rational Clinical Examination
Original Article: Does This Patient Have a Family History of Cancer?